Recombinant Escherichia coli O127:H6 Galactokinase (galK)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
galK; E2348C_0634Galactokinase; EC 2.7.1.6; Galactose kinase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-382
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O127:H6 (strain E2348/69 / EPEC)
Target Names
galK
Target Protein Sequence
MSLKEKTQSL FANAFGYPAT RTIQAPGRVN LIGEHTDYND GFVLPCAIDY QTVISCAPRD DRKVRVMAAD YENQLDEFSL DAPIVAHENY QWANYVRGVV KHLQLRNNSF GGVDMVISGN VPQGAGLSSS ASLEVAVGTV LQQLYHLPLD GAQIALNGQE AENQFVGCNC GIMDQLISAL GKKDHALLID CRSLGTKAVS MPKGVAVVII NSNFKRTLVG SEYNTRREQC ETGARFFQQP ALRDVTIEEF NAVAHELDPI VAKRVRHILT ENARTVEAAS ALEQGDLKRM GELMAESHAS MRDDFEITVP QIDTLVEIVK AVIGDKGGVR MTGGGFGGCI VALIPEELVP AVQQAVAEQY EAKTGIKETF YVCKPSQGAG QC
Uniprot No.

Target Background

Function
Catalyzes the transfer of ATP's gamma-phosphate to D-galactose, forming alpha-D-galactose-1-phosphate (Gal-1-P).
Database Links
Protein Families
GHMP kinase family, GalK subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Galactokinase (galK) and what is its function in bacterial metabolism?

Galactokinase (galK) is an enzyme in the Escherichia coli galactose operon that catalyzes the first step in the galactose degradation pathway, specifically phosphorylating galactose to galactose-1-phosphate. The galactose operon consists of four genes: galE, galT, galK, and galM, which collectively enable bacteria to utilize galactose as a carbon source. This phosphorylation step is critical as it activates galactose for subsequent metabolic processing in the Leloir pathway .

The biological significance of galK extends beyond its metabolic role, as it has been utilized as a powerful genetic tool. The enzyme can phosphorylate both galactose and its analog 2-deoxy-galactose (DOG), with the latter reaction producing 2-deoxy-galactose-1-phosphate that cannot be further metabolized and becomes toxic to the cell. This dual functionality allows galK to serve as both a positive and negative selection marker in genetic manipulation experiments .

How does galK selection work in bacterial systems?

The galK selection system operates on dual selection principles that make it particularly valuable for genetic engineering:

Positive Selection: Bacteria containing a functional galK gene can metabolize galactose as their sole carbon source. When grown on minimal media with galactose, only cells expressing functional galactokinase will form colonies. This allows researchers to select for cells that have successfully incorporated the galK gene .

Negative Selection: Conversely, bacteria expressing galK will phosphorylate the galactose analog 2-deoxy-galactose (DOG) to 2-deoxy-galactose-1-phosphate, which accumulates in the cell and becomes toxic. When plated on media containing DOG, only cells that have lost the functional galK gene will survive. This provides a powerful counterselection mechanism .

This dual-selection capability allows researchers to perform sophisticated genetic modifications, particularly in bacterial artificial chromosome (BAC) engineering, with minimal background and high specificity .

How is pgalK constructed for recombineering applications?

The construction of pgalK, a plasmid containing the galK gene driven by the prokaryotic em7 promoter, involves a two-stage PCR amplification process:

First PCR Round:

  • Template: Genomic DNA from W3110 E. coli strain

  • Primers: galK ORF 1st F (5′-CCCAGGAGGCAGATCATGAGTCTGAAAGAAAAAACACAATCTCTGT-3′) and galK ORF R (AATAAAGGATCCTCAGCACTGTCCTGCTCCTT-3′)

  • Conditions: 94°C for 15s, 60°C for 30s, 72°C for 1.5 min, 30 cycles

Second PCR Round:

  • Template: Product from first PCR

  • Primers: galK ORF 2nd F (containing the em7 promoter sequence) and galK ORF R

  • Conditions: Same as first round

The final PCR product is gel purified, digested with EcoRI and BamHI restriction enzymes, and cloned into similarly digested pBluescript SK- vector. The resulting plasmid is verified by sequencing and can be used as a template for amplifying the galK cassette with homology arms for recombineering .

What is the protocol for introducing point mutations using galK selection?

The process of introducing precise point mutations using galK selection follows this methodological framework:

  • Design and Preparation of galK Cassette:

    • Design PCR primers with 50 bp homology arms flanking the target mutation site

    • Amplify the galK expression cassette (~1231 bp) using these primers

    • Purify the PCR product for electroporation

  • First Recombination (Insertion of galK):

    • Heat-induce recombineering enzymes in the bacterial strain containing your target BAC

    • Transform bacteria with the purified galK cassette via electroporation

    • Select positive recombinants on galactose minimal medium with appropriate antibiotics

    • Purify colonies by streaking on MacConkey galactose indicator plates (Gal+ colonies appear bright pink/red)

  • Second Recombination (Replacement with Mutation):

    • Design and synthesize double-stranded DNA containing your desired mutation with the same homology arms

    • Perform a second round of recombineering to replace galK with the mutated sequence

    • Select on minimal media containing 2-deoxy-galactose (DOG) for loss of galK

    • Verify the mutation by sequencing

A concrete example from research literature describes introducing a G12D mutation in the murine Nras gene by changing codon 12 from GGT to GAT. Researchers designed primers with 50 bp homology to either side of the target codon and successfully introduced the mutation using the two-step galK selection process .

What storage and handling protocols maximize recombinant galK stability?

Optimal storage and handling of Recombinant Escherichia coli O127:H6 Galactokinase requires careful attention to temperature, buffer composition, and reconstitution procedures:

Storage ConditionRecommendationDuration
Short-term storage-20°CUp to 6 months (liquid form)
Extended storage-80°CUp to 12 months (lyophilized form)
Working aliquots4°CUp to one week

Reconstitution Protocol:

  • Centrifuge the vial briefly before opening to bring contents to the bottom

  • Reconstitute protein in deionized sterile water to 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% (50% is recommended)

  • Aliquot to minimize freeze-thaw cycles

It is critical to avoid repeated freezing and thawing as this significantly reduces enzymatic activity. For optimal results, make single-use aliquots after initial reconstitution .

How does galK selection compare with other BAC recombineering systems?

The galK selection system offers several significant advantages over alternative selection markers used in bacterial artificial chromosome (BAC) recombineering:

Selection SystemSizeSelection TypeBackground LevelScreening Requirement
galK~1231 bp + homology armsDual positive/negativeLowNot required
sacB-neo~3000 bpDual positive/negativeMediumOften required
amp/kan~1000 bpPositive onlyHighRequired

The comparatively small size of the galK cassette makes it easier to amplify by PCR and transform into bacteria with higher efficiency. Moreover, because the same gene (galK) is used for both positive and negative selection, background colonies following counterselection are significantly reduced .

Another key advantage is that the galK system doesn't require colony screening using techniques like PCR or Southern blotting, as colonies that survive both selection stages have very high recombination fidelity. This streamlines the workflow and increases experimental throughput for complex genetic modifications .

What are the critical factors affecting the efficiency of galK-based recombineering?

Several experimental parameters significantly impact the efficiency of galK-based recombineering:

Homology Arm Length: The optimal length of homology arms flanking the galK cassette is typically 50 bp. Shorter arms result in dramatically reduced recombination efficiency, while longer arms (>50 bp) yield only marginal improvements while making primer synthesis more difficult and expensive.

Bacterial Strain Selection: Recombineering strains (such as SW102, SW105, and SW106) that have been specifically developed for galK selection provide significantly higher efficiency than standard laboratory strains. These strains are deficient in endogenous galK but contain the necessary λ Red recombination system.

Induction Timing: Heat induction of the λ Red recombination system requires precise timing. Optimal induction occurs at 42°C for 15 minutes, with efficiency decreasing significantly with shorter or longer induction periods.

Selection Media Composition: The composition of both galactose minimal media (for positive selection) and DOG-containing media (for negative selection) is critical. Trace contaminants of glucose or other carbon sources can dramatically reduce selection stringency .

How can researchers design experiments to detect subtle phenotypic effects of galK mutations?

Designing experiments to detect subtle phenotypic effects of galK mutations requires careful control design and quantitative analysis approaches:

Complementation Studies: One effective approach is to introduce wild-type or mutant galK genes into galK-deficient strains and measure growth rates in galactose-containing media. Subtle differences in enzyme activity can be detected by comparing growth curves rather than endpoint measurements.

Enzymatic Activity Assays: Direct measurement of galactokinase activity can be performed using radioactive or fluorescent galactose analogs. The rate of phosphorylation can be monitored in real-time, providing sensitive detection of functional changes in mutant enzymes.

Metabolic Flux Analysis: More sophisticated techniques like metabolic flux analysis using 13C-labeled galactose can provide insights into how galK mutations affect the broader metabolic network. This approach can detect compensatory mechanisms that might mask phenotypic effects in simpler assays.

Competitive Growth Assays: Co-culturing wild-type and mutant strains in varying ratios and monitoring population dynamics over many generations can amplify subtle fitness differences that might be undetectable in isolation .

What are common challenges in galK-based recombineering and how can they be addressed?

Researchers commonly encounter several challenges when implementing galK-based recombineering systems:

High Background in Negative Selection: If too many colonies appear after counterselection on DOG plates, potential causes include:

  • Insufficient DOG concentration (Solution: Increase DOG concentration to 0.2%)

  • Spontaneous galK mutations (Solution: Verify by PCR or sequencing)

  • Contamination of media with carbon sources (Solution: Use ultrapure reagents)

Low Transformation Efficiency: If few or no colonies appear after positive selection, consider:

  • DNA quality issues (Solution: Use freshly prepared, concentrated DNA)

  • Suboptimal induction of recombination enzymes (Solution: Optimize heat-shock parameters)

  • Poor electroporation efficiency (Solution: Ensure cells are washed thoroughly to remove salts)

False Positive Colonies: Pink colonies on MacConkey galactose plates that aren't truly Gal+ may result from:

  • Partial galK function (Solution: Re-streak to confirm consistent phenotype)

  • Contamination with other bacteria (Solution: Verify strain identity)

How can researchers interpret kinetic data from galactokinase enzymatic assays?

Interpretation of kinetic data from galactokinase enzymatic assays requires careful analysis of several parameters:

Michaelis-Menten Kinetics: The key parameters to determine are:

  • Km (substrate concentration at half-maximal velocity) - indicates enzyme affinity for substrate

  • Vmax (maximum reaction velocity) - reflects catalytic capacity

  • kcat (turnover number) - represents catalytic efficiency

Typical Michaelis-Menten parameters for wild-type E. coli galactokinase are:

  • Km for galactose: approximately 0.4 mM

  • Km for ATP: approximately 0.3 mM

  • kcat: approximately 8 s-1

Deviations from these values in recombinant or mutant galK proteins may indicate altered substrate binding, catalytic efficiency, or structural changes affecting the active site. When interpreting such deviations, researchers should consider both statistical significance and biological relevance.

For inhibition studies, determining the inhibition constant (Ki) and mode of inhibition (competitive, non-competitive, or uncompetitive) provides insights into potential regulatory mechanisms and structural constraints of the enzyme.

What emerging applications of galK are currently being developed?

Emerging applications of the galK selection system extend beyond traditional genetic engineering approaches:

CRISPR-Cas9 Integration: Combining galK selection with CRISPR-Cas9 technology allows for more precise and efficient genomic modifications. The galK marker can be used to select for successful integration of CRISPR components, followed by seamless removal through counterselection.

Synthetic Biology Circuit Design: The dual-selection capability of galK makes it valuable for building and testing genetic circuits with multiple components. Researchers can sequentially add and modify circuit elements using alternating rounds of positive and negative selection.

Directed Evolution Studies: The galK system provides an excellent platform for directed evolution experiments. By introducing random mutations and selecting for altered galactokinase function, researchers can study enzyme evolution and develop variants with novel properties.

Vaccine Development: The ability to make precise genetic modifications using galK selection facilitates the development of live attenuated vaccines, where specific genes can be modified or deleted to reduce pathogenicity while maintaining immunogenicity .

How might computational approaches enhance galK-based experimental design?

Computational methods are increasingly important for optimizing galK-based experimental design:

Homology Arm Optimization: Algorithms can predict optimal homology arm sequences by analyzing factors like GC content, secondary structure, and uniqueness within the target genome, potentially improving recombination efficiency.

Protein Structure Prediction: Advanced protein folding algorithms (like AlphaFold) can predict how mutations might affect galK structure and function, guiding rational design of variants with desired properties.

Machine Learning for Protocol Optimization: By analyzing experimental outcomes across multiple laboratories, machine learning models can identify patterns in successful versus failed recombineering attempts, providing data-driven recommendations for protocol optimization.

In Silico Screening: Virtual screening of potential inhibitors or substrates can accelerate the development of new galK-based selection systems with altered specificity or improved performance characteristics .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.